A colleague with our law firm published an article in the Legal Examiner discussing the spying controversy with the Food and Drug Administration (FDA). A recent news report in the Washington Post stated that lawyers for the FDA authorized electronic surveillance of scientists who worked for the FDA. The surveillance involved monitoring employee’s email accounts when accessed via work computers, taking screen shots of those computers, and alerting about program activity and printing. The FDA contends it was chiefly concerned with its scientists improperly disclosing confidential business information or trade secrets about medical devices. To learn more, read the story here:
FDA Spying Controversy Underscores Need to Support Scientists